findmyKOL

Wendy Matis, MD

Basic profile

Dermatology

ORCIDNone on fileNPI
RegionSalt Lake City, UT · WestSpecialtyDermatologyFocusDermatology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication1990Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Wendy Matis is a Dermatology physician. OpenAlex indexes 7 publications with 633 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
7publications

Distinct works indexed by OpenAlex.

633citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

710 E 200 S
Ste 1b
Salt Lake City, UT 841022265

Telephone

801-521-0100

Registry record last updated 25 Jan 2016.

View the NPPES registry record

Industry payments

2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    42.5%
    Azole Antifungal9.4%
    Ketoconazole100%
    Part D33 patients
    Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor7.6%
    Famciclovir100%
    Part D20 patients

    + 5 more classes in this area

  • Sensory organs

    21.7%
    Corticosteroid21.7%
    Clobetasol Propionate35%Desonide33%Betamethasone Dipropionate17%Betamethasone Diprop Augmented15%
    Part D<11 patients
  • Respiratory

    19.3%
    Corticosteroid16.9%
    Mometasone Furoate100%
    Part D72 patients
    RNA Synthetase Inhibitor Antibacterial2.4%
    Mupirocin100%
    Part D11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”